课题基金 / 基金详情

PHASE I/II STUDY OF SNX-111 ADMINISTERED TO TERMINAL PATIENTS IN CHRONIC PAIN

PHASE I/II STUDY OF SNX-111 ADMINISTERED TO TERMINAL PATIENTS IN CHRONIC PAIN
SNX-111 用于慢性疼痛末期患者的 I/II 期研究
批准号:
5215990
负责人:
MICHAEL G BYAS-SMITH
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

MICHAEL G BYAS-SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this study is to asses the safety, tolerability and analgesic effects of rising doses of SNX-111, administered intrathecally to terminally ill patients who suffer from chronic pain and have had an unsatisfactory response to opioid therapy. SNX-111 is a new type of calcium channel blocker that specifically blocks N-type neuron-specific, voltage-sensitive calcium channels which are found at presynaptic nerve terminals. This is a multicenter study, where 30 patients are expected to enroll, 5 of which will be studied at Emory. Two patients have been evaluated. The protocol is currently being modified for resubmission to the GAC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PAIN RESPONSE BEFORE AND AFTER MORPHINE ADMINISTRATION
  • 批准号:
    6244371
  • 项目类别:
  • 资助金额:
    $3.62万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL G BYAS-SMITH
  • 依托单位:
THERMAL SENSORY EFFECTS OF CAPSAICIN ON ORAL MUCOSA--NORMALS
  • 批准号:
    6244367
  • 项目类别:
  • 资助金额:
    $3.62万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL G BYAS-SMITH
  • 依托单位:
NEUROSENSORY TESTING AND MECHANISMS OF NEUROPATHIC PAIN
  • 批准号:
    6244332
  • 项目类别:
  • 资助金额:
    $3.62万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL G BYAS-SMITH
  • 依托单位:
PHASE I/II STUDY OF SNX-111 ADMINISTERED TO TERMINAL PATIENTS IN CHRONIC PAIN
  • 批准号:
    6244344
  • 项目类别:
  • 资助金额:
    $3.62万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL G BYAS-SMITH
  • 依托单位:
海外基金